Literature DB >> 28820348

Where to now? AVERT answered an important question, but raised many more.

Mark T Bayley1,2, Audrey Bowen3, Coralie English4, Robert Teasell5, Janice J Eng6.   

Abstract

A Very Early Rehabilitation Trial (AVERT) was a Phase 3 randomized trial with over 2100 subjects post stroke that had unexpected results with better outcomes for usual care than those receiving very early mobilization. This review of published stroke clinical practice guidelines highlights that recommendations for mobilization have changed after publication of AVERT but also that developers have struggled to provide recommendations for appropriate dose, duration and intensity of mobilization in the acute post stroke period with available analyses from AVERT and other literature. This review highlights the priority research questions about early rehabilitation post stroke that need to be addressed through future large scale randomized controlled trials.

Entities:  

Keywords:  Acute stroke; clinical practice guidelines; rehabilitation; research priorities

Mesh:

Year:  2017        PMID: 28820348     DOI: 10.1177/1747493017727338

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

1.  Early Mobilization After Stroke: Do Clinical Practice Guidelines Support Clinicians' Decision-Making?

Authors:  Venesha Rethnam; Kathryn S Hayward; Julie Bernhardt; Leonid Churilov
Journal:  Front Neurol       Date:  2021-02-05       Impact factor: 4.003

2.  Can Early Neuromuscular Rehabilitation Protocol Improve Disability after a Hemiparetic Stroke? A Pilot Study.

Authors:  Mahdi Yazdani; Ahmad Chitsaz; Vahid Zolaktaf; Mohammad Saadatnia; Majid Ghasemi; Fatemeh Nazari; Abbas Chitsaz; Katsuhiko Suzuki; Hadi Nobari
Journal:  Brain Sci       Date:  2022-06-22

3.  Fatal and non-fatal events within 14 days after early, intensive mobilization post stroke.

Authors:  Julie Bernhardt; Karen Borschmann; Janice M Collier; Amanda G Thrift; Peter Langhorne; Sandy Middleton; Richard I Lindley; Helen M Dewey; Philip Bath; Catherine M Said; Leonid Churilov; Fiona Ellery; Christopher Bladin; Christopher M Reid; Judith H Frayne; Velandai Srikanth; Stephen J Read; Geoffrey A Donnan
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.